Eltrombopag in adult patients with immune thrombocytopenia in the real-world in France, including off-label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study.

ABSTRACT:

SUBMITTER: Moulis G 

PROVIDER: S-EPMC9300059 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature